Prasanna Gullapalli

Thu, December 18, 2025 at 3:27 PM GMT+5:30

1 min read

The Kricket PAP device

The US Food and Drug Administration (FDA) has granted 510(k) clearance to SleepRes’ Kairos positive airway pressure (KPAP)-powered Kricket PAP device for the treatment of obstructive sleep apnoea (OSA).

Intended for patients weighing more than 66lb, the device is suitable for use in hospitals, institutional settings, homes, and sleep centres.

The KPAP sleep therapy platform is developed to offer an adaptive and patient-focused alternative to traditional continuous positive airway pressure (CPAP) therapy.

According to the company, the KPAP technology is designed to adjust pressure delivery throughout the breathing cycle, in contrast to the fixed pressure maintained by conventional CPAP devices.

This approach aims to synchronise therapy with the patients' natural breathing patterns and airway dynamics, potentially reducing discomfort and improving sleep tolerance.

SleepRes founder and KPAP inventor William Noah said: “Today completes a 4+ year pursuit to provide my own patients with technology designed to emulate natural breathing and address the discomfort and pressure intolerance common with traditional CPAP.”

The device offers KPAP, traditional CPAP, and automatic PAP therapy modes.

SleepRes is planning to introduce the Kricket device commercially in the first half of 2026 and is currently preparing to expand manufacturing, develop clinical collaborations, and offer insights on the KPAP system before the launch.

SleepRes' chief medical officer David White said: “Kricket opens the door to a new category of positive airway pressure therapy that prioritises comfort, the patient's ability to adapt, and real-world use, while still delivering the therapy patients need.

“That balance is critical if we want to meaningfully improve long-term outcomes for people living with obstructive sleep apnoea.”

More in Business

Owner of Michael Jordan’s $9.5 Million Chicago Mansion Sparks Neighbors’ Fury With Plans To Turn Home Into ‘Immersive’ Museum

Realtor.com

644

75-year-old department store brand closing forever

TheStreet

59

Michael Saylor Buys Another $1B in Bitcoin as Grayscale Predicts All Time High Within 6 Months — Is It Likely?

CCN

66

India's New Income Trend - Could It Work For You?SmartAI

Ad

"FDA clears SleepRes’ Kricket PAP device for obstructive sleep apnoea" was originally created and published by Medical Device Network, a GlobalData owned brand.

The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.